Shanghai Siponuoyin Biotechnology Co Ltd
1 clinical trials · Sponsor
◉ Watch Shanghai Siponuoyin Biotechnology Co Ltd
| Record | Firm | Date |
|---|---|---|
| Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients (NCT07188012) | Shanghai Siponuoyin Biotechnology Co Ltd | 2025-08-06 |
Track Shanghai Siponuoyin Biotechnology Co Ltd automatically
Every clearance here is in the API, with alerts when new ones post.